Trump trade war affects medical industry | Dozens of products such as insulin enter the taxation list

A few days ago, the U.S. Trade Representative’s Office published a list of tariffs to be imposed on Chinese products in accordance with the previous request of President Trump.

It is understood that this list covers 1300 independent tariff items covering aerospace, information technology, communications engineering, automated robotics, and medical fields. Among them, in the medical field, the included taxation list includes the use of diabetics. Insulin, adrenergic resistance to allergic reactions, and vaccines, blood products and antidepressants, syringes, nuclear magnetic resonance equipment, defibrillators, artificial joints, and pacemakers, etc. In the future, the United States intends to add to these Chinese products 25 % of punitive tariffs.

However, the above list cannot be implemented immediately. In the next 60 days of 'public consultation period', the U.S. public can comment on this proposed list of attacks and participate in the hearing. The U.S. government may, as appropriate, Adjustments, this list will not be implemented until June this year.

According to the latest report of Xinhua News Agency, in response to the just-announced tax levying on China’s 301 survey by the U.S. Trade Representative’s Office, a spokesperson for the Ministry of Commerce issued a speech at the first time, stating that China strongly opposes and will apply the same force to U.S. products in accordance with law. , Peer-to-peer measures of equal size.